Pre-market Hot Trades in US Stocks

House of Doge, up 8.70% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Catheter Precision, down 7.59% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Top Gainers in Pre-market US Stocks

Q32 Bio, up 74.04% in pre-market. Based on recent key news:

1. On July 13, Q32 Bio announced the 36-week trial results of its bempikibart drug for treating severe alopecia areata patients, showing an average hair regrowth improvement of 35.3%, with about 40% of patients achieving significant scalp coverage. This news drove the stock price up by 56%. Source: PR Newswire

2. On July 11, Q32 Bio announced it would release the 36-week topline results of its SIGNAL-AA trial on July 13 and plans to conduct a larger-scale registration study in 2027. This news increased market confidence in the company's future development. Source: Public Technologies

3. On July 10, Q32 Bio stated it does not undertake any obligation to update any forward-looking information, emphasizing the company's cautious attitude towards future developments. This statement did not have a direct impact on the stock price. Source: Argot Partners. The biotechnology sector has recently performed strongly, with significant capital inflows.

Fast Track, up 50.58% in pre-market. Based on recent key news:

1. On July 10, Fast Track Entertainment completed a senior secured convertible note financing with US institutional investors, raising $1.5 million. This move aims to support the company's growth plans, including strategic partnerships, IP-driven projects, digital content development, audience growth, and platform expansion. This financing activity boosted market confidence in the company's future growth potential, significantly driving up the stock price. Source: Public Technologies

2. On July 10, the company also arranged a $20 million equity credit facility with an affiliate of investors. This arrangement provides the company with further financial flexibility to support its expansion plans, further boosting investor confidence. Source: Public Technologies

3. On July 10, the company aims to deepen its participation in the broader entertainment value chain and enhance revenue resilience by combining event execution with IP ownership and recurring monetization channels. This strategic shift reflects the company's transformation towards scalable, technology-driven entertainment products, aligning with changes in global entertainment and media consumption patterns. Source: Public Technologies. The entertainment industry is transforming, with a clear trend towards digitalization Anterion's stock rose 47.76% in pre-market trading. Based on recent news,

4. On July 13, Anterion announced it secured up to $340 million in private financing, led by Commodore Capital, with participation from RA Capital Management and others. This funding will support the late-stage trials of its experimental cancer drug combination botensilimab and balstilimab in high-risk colorectal cancer patients. This news drove the stock price up by 22.4%.

5. On July 13, Anterion announced it would cease funding for another late-stage colorectal cancer study to concentrate resources on the new trial. This move was interpreted by the market as a strategic adjustment by the company, further boosting investor confidence.

6. On July 13, Anterion stated that the financing includes $85 million in upfront funds and up to $255 million in warrant exercise funds, which is expected to support the company's operations until the end of 2031. This news enhanced market confidence in the company's long-term development, driving the stock price up. The biotechnology sector has shown strong performance recently, with significant capital inflows